ResearchMoz

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2014-03-06
No. Of Pages » 68
 This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR)...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rise in diabetic population globally
3.2.2 Rise in demand for point of care testing (POCT)
3.3 Market Restraints
3.3.1 Unfavourable reimbursement policies
3.3.2 Calibration issues
3.4 Market Opportunities
3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
3.5 Porter’s Five Forces Analysis for the Global Continuous Glucose Monitoring Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography

Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million)
4.1 Overview
4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
4.2 Guardian Real Time CGM System
4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
4.3 FreeStyle Navigator
4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
4.4 Dexcom Seven Plus CGM System
4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
4.5 Dexcom G4 Platinum
4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
4.6 MiniMed Paradigm Revel/Veo System
4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)

Chapter 5 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
7.2 Investing in research and development of technologically advanced products with added benefits
7.3 Emphasis on price control

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Bayer AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Dexcom, Inc.
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 GlySens Incorporated
8.4.1 Company overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.5 Insulet Corporation
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Medtronic, Inc.
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Nova Biomedical Corporation
8.7.1 Company overview
8.7.2 Product portfolio
8.7.3 Business Strategies
8.7.4 Recent Developments
8.8 Senseonics, Incorporated
8.8.1 Company overview
8.8.2 Product portfolio
8.8.3 Business Strategies
8.8.4 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
TABLE 4 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Continuous Glucose Monitoring: Market Segmentation
FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Continuous Glucose Monitoring Market
FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
FIG. 5 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
FIG. 6 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
FIG. 8 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
FIG. 10 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 18 Annual Revenue: Bayer AG., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenue: Dexcom, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenue: Insulet Corporation, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenue: Medtronic, Inc., 2010 – 2012 (USD Million)

Upcoming Reports:

Opportunities of Composites in the Global Automotive Market - Global Industry Size, Market Share, Trends, Analysis, and Forecast, 2012 - 2018
By - Transparency Market Research
Composites (glass fibers, resins, and carbon fibers) find their application in several sectors of the global market including the automotive market. There are several benefits of using composites in vehicles. It renders greater resistance to heat, makes the car lighter, and improves the fuel efficiency of the vehicle. New infrastructure projects, growth in population, environmental awareness, and urbanization are some of the factors likely to drive the market of composites in the automotive industry. Some of the factors hampering the growth of composites in the automotive...
Collagen And HA-Based Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Biomaterials are one of the most vital materials used in healthcare and pharmaceutical industry. They are natural or synthetic materials used for the development of synthetic organs, prosthetics, therapeutics and storage applications. They can be obtained from nature or synthesized in the laboratory with the aid of various chemical synthesis procedures.  Biomaterials are extensively used to replace or repair damaged tissues, such as bone and cartilage regeneration. Their wide areas of application include orthopedic surgery, dental surgery, cosmetic surgery, tissue regeneration,...
Fault Current Limiter/Controller Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Fault Current is any abnormal current in an electrical power system. An electrical fault may occur due to short circuit, where the current bypasses the normal load. Fault Current Limiters (FCL’s) are devices used in power systems that are used to control the power wastage. FCL’s limit the amount of current flowing through the systems and allows for the continual uninterrupted operation of the system, thereby reducing the risk of fault and enhancing the safety of the consumer. FCL is one of the emerging markets with a number of manufacturers offering prototypes for...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...
Pharmaceutical Companies in Europe to Share Deprioritized Compounds for Medical Research
Jul 23, 2014  
Seven leading drugmakers in the UK have decided to share their unused experimental medicines with British researchers involved in academic research. This move is seen as an effort to deepen relations between the pharmaceutical industry and the community of scientists in the country. The new partnership between the seven pharma companies and the Medical Research Council (MRC) was...
Xiaomi Broadens Line-Up With Bigger Screen Phones
Jul 23, 2014  
Targeting the market of larger mobile phones, Xiaomi Corp. is all set to launch a 5-inch screen smartphone next week. The smartphone maker that beats Apple Inc. in China in terms of sales is broadening its line-up of electronic devices in order to challenge Samsung and Apple who dominate the market in developed countries such as the U.S. Apple is also said to be launching its latest version of...
Sony To Invest USD 345 Million In Image Sensors
Jul 23, 2014  
Sony Corp plans on investing USD 345 million in image sensors in its smartphones and tablets to enhance front-camera experience as the ‘selfie’ trend goes viral. Two CMOS sensors manufacturing factories will see an increase in production. These units – Nagasaki and Kumamoto Technology Centres – are based in Kyushu, an island situated in southern Japan. With the said...
Typhoon Rammasun hits Yangjiang, Guangdong province
Jul 22, 2014  
The largest typhoon to hit the southern part of China in forty years has resulted in death of 17 people after wreaking havoc on Philippines. The typhoon Rammasun has resulted in deaths of eight people on the island of Hainan. Many people are recorded missing and nine of these from the Guangxi region. This typhoon caused landfall on Friday, and was reported with winds exceeding 200...